Comparative Long-Term Effect of Three Anti-P2Y12 Drugs after Percutaneous Angioplasty: An Observational Study Based on Electronic Drug Adherence Monitoring

Aims: Dual platelet inhibition using anti-P2Y12 drugs and aspirin is the standard of care in patients after percutaneous coronary interventions (PCI). Prasugrel and ticagrelor have been shown to be more potent than clopidogrel with less high on-treatment platelet reactivity. Whether differences in l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Forni Ogna, Valentina, Bassi, Isabelle, Menetrey, Isabelle, Muller, Olivier, Tousset, Eric, Fontana, Pierre, Eeckhout, Eric, Eap, Chin B., Vrijens, Bernard, Burnier, Michel, Wuerzner, Grégoire
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2017
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5660969/
https://ncbi.nlm.nih.gov/pubmed/29118712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00738
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados